SC 13G

Company

Kura Oncology, Inc.

Filed

November 16, 2015

Accession Number

0001144204-15-065971

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →